These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6959574)

  • 1. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effectiveness of long-term treatment of patients with rheumatoid arthritis by using gold salts and D-penicillamine].
    Trofimova TM; Alekberova ZS; Speranskiĭ AI; Beresten' TI; Tarasenkova TA
    Revmatologiia (Mosk); 1988; (1):13-7. PubMed ID: 3291056
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
    Malaise MG; Davin JC; Mahieu PR; Franchimont P
    Clin Immunol Immunopathol; 1986 Aug; 40(2):356-64. PubMed ID: 2941196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA deficiency and drug induced IgA deficiency in rheumatoid arthritis.
    Mbuyi JM; Dequeker J; Francx L
    J Rheumatol; 1983 Oct; 10(5):829-31. PubMed ID: 6644713
    [No Abstract]   [Full Text] [Related]  

  • 7. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of rheumatoid arthritis with gold preparations under control of their concentration in the blood serum].
    Beresten' TI; Trofimova TM
    Ter Arkh; 1980; 52(2):102-6. PubMed ID: 7376087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness and complications of chrysotherapy of rheumatoid arthritis].
    Erov NK
    Revmatologiia (Mosk); 1986; (1):11-4. PubMed ID: 2940663
    [No Abstract]   [Full Text] [Related]  

  • 11. Bronchoalveolar lavage and gold salt-induced pneumonitis.
    Breton JL; Garnier G; Toulouse J; Depierre A
    Chest; 1985 Mar; 87(3):410. PubMed ID: 3971774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of an aplastic syndrome after chrysanol administration].
    Biriukova IV; Predtechenskaia VS
    Vopr Revm; 1982; (1):67-8. PubMed ID: 7090317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatoid factors during controlled krizanol treatment of rheumatoid arthritis patients].
    Alekberova ZS; Trofimova TM; Speranskiĭ AI; Beresten' TI
    Revmatologiia (Mosk); 1985; (3):19-22. PubMed ID: 3903922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute colitis during treatment with gold salts].
    Manigand G; Dumont D; Faux N; Taillandier J; Gaultier T; Fritsch J; Szekely AM
    Presse Med; 1983 Oct; 12(34):2112-3. PubMed ID: 6226039
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.
    Reychler R; De Geeter T; Verbruggen LA
    Clin Rheumatol; 1986 Jun; 5(2):275-7. PubMed ID: 3731724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diffuse pneumopathy with digital vasculitis in rheumatoid arthritis. Probable role of gold].
    Hauteville D; Vinti H; Simon A; Alvin R
    Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):56-7. PubMed ID: 6695143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of chrysanol in rheumatoid arthritis].
    Urbaniuk KG; Mazurets AF; Kobranova GP; Zarapin VP
    Vrach Delo; 1983 Jan; (1):37-40. PubMed ID: 6868495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fatal hepatic necrosis due to a treatment course of rheumatoid arthritis with gold salts].
    Van Linthoudt D; Buss W; Beyner F; Ott H
    Schweiz Med Wochenschr; 1991 Jul; 121(30):1099-102. PubMed ID: 1678206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.